Hematologic toxicity and transfusional requirement following high-dose etoposide, high-dose CTX, and autograft
| Parameters . | Hd VP16 . | Hd-CTX . | MITO/L-PAM . |
|---|---|---|---|
| Days with WBC < 0.5 × 109/L | 3 (0-8) | 5 (0-9) | 8 (3-14) |
| Days with platelets < 20 × 109/L | 3 (0-7) | 5 (0-10) | 10 (5-20) |
| Median no. of platelet transfusions (range) | 0 (0-3) | 1 (0-6) | 3 (0-8) |
| Median no. of RBC transfusions (range) | 0 (0-4) | 1 (0-9) | 2 (0-8) |
| Parameters . | Hd VP16 . | Hd-CTX . | MITO/L-PAM . |
|---|---|---|---|
| Days with WBC < 0.5 × 109/L | 3 (0-8) | 5 (0-9) | 8 (3-14) |
| Days with platelets < 20 × 109/L | 3 (0-7) | 5 (0-10) | 10 (5-20) |
| Median no. of platelet transfusions (range) | 0 (0-3) | 1 (0-6) | 3 (0-8) |
| Median no. of RBC transfusions (range) | 0 (0-4) | 1 (0-9) | 2 (0-8) |
Hd indicates high-dose; WBC, white blood cells; RBC, red blood cells.